Search clinical trials for: Breast cancer

Total 87698 results

Rossella Elia, MD PhD

Recruiting

Pre-pectoral Tissue Expander and Acellular Dermal Matrix for a Two-stage Muscle Sparing Breast Reconstruction

Breast Cancer

Italy
Washington University School of Medicine
United States Department of Defense; Aclaris Therapeutics, Inc.

Not yet recruiting

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer

United States
M.D. Anderson Cancer Center
Siemens Medical Solutions

Not yet recruiting

Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems

Architectural Distortions | Breast Tomosynthesis

United States
Fundacao Champalimaud

Not yet recruiting

Trial for Treatment of High Risk BC With Two Sequences of Neoadjuvant Chemotherapy With Pembrolizumab (KEYPARTNER)

Triple Negative Breast Cancer | Early Breast Cancer

Portugal
ABSCINT NV/SA

Not yet recruiting

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer

Belgium
Sakarya University

Recruiting

Breast Cancer and Breast Self-examination Education

Breast Cancer | Breast Self-Examination

Turkey
Duke University

Not yet recruiting

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors (AYA STEPS)

Sarcoma | Lymphoma | Cancer | Breast Cancer | Colorectal Cancer | Testicular Cancer
First Affiliated Hospital of Zhejiang University
Shanghai Longfine Biotechnology Co., Ltd.; TopAlliance

Not yet recruiting

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Triple-negative Breast Cancer

China
Kliniken Essen-Mitte
Karl and Veronica Carstens Foundation

Not yet recruiting

Auricular Acupuncture and Hot Flashes During Adjuvant Endocrine Therapy (OhrHit)

Hot Flashes
Wuhan Union Hospital, China

Recruiting

Cadonilimab Combined With Chemotherapy as First or Second Line Treatment in Recurrent or Metastatic Triple Negative Breast Cancer

Triple-negative Breast Cancer | Cadonilimab

China
Puma Biotechnology, Inc.

Not yet recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer (ALISCA-Breast1)

Metastatic Breast Cancer | Recurrent Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer

United States
Andrea DeCensi
Herbert Irving Comprehensive Cancer Center; Breast Cancer Research Foundation; Istituto Europeo di Oncologia and other collaborators

Not yet recruiting

Babytam vs Babyexe in Post-menopausal Women at High Risk for Breast Cancer. (BabyTears)

Breast Cancer

Italy
Universitaire Ziekenhuizen KU Leuven
Eli Lilly and Company; Kom Op Tegen Kanker; Teva Pharma

Recruiting

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer (ABBICAR)

Triple Negative Breast Neoplasms

Belgium
Huihua Xiong

Not yet recruiting

A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer

Breast Cancer
Medical College of Wisconsin

Not yet recruiting

Molecular Analyses to Identify Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer

Breast Cancer

United States
The Netherlands Cancer Institute

Recruiting

Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer (PAPBI-3)

Breast Cancer

Netherlands
Huihua Xiong

Not yet recruiting

SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases

Breasr Cancer
Penn State University
University of Ghana

Not yet recruiting

Breast Cancer Screening in Ghana

Breast Cancer Female
Beijing Friendship Hospital

Recruiting

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Cholangiocarcinoma | Thyroid Cancer | Liver Cancer

China
Cardenal Herrera University

Not yet recruiting

Impact of Nipple Micropigmentation in Mastectomized Women

Body Image | Female Sexual Function | Self Esteem | Intimacy With Your Partner
Institut Nacional d'Educacio Fisica de Catalunya
Hospital Clinic of Barcelona; Institut d'Investigacions Biomèdiques August... and other collaborators

Recruiting

Prehabilitation Exercise Program in Breast Cancer: Effects on Quality of Life and Tumor Microenvironment (PEP_BC) (PEP_BC)

Breast Cancer

Spain
KARANAHAN

Recruiting

Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide

Stage IV Breast Cancer

Russian Federation
UNC Lineberger Comprehensive Cancer Center

Recruiting

Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials

Breast Cancer

United States
University Hospital, Bordeaux

Not yet recruiting

Gynaecological Care for Transgender People in France in 2024. (GyneTrans)

Transgender Management Care

France
Fudan University

Recruiting

Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

Breast Cancer

China
Swiss Group for Clinical Cancer Research

Not yet recruiting

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

Triple-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer

Switzerland
Center Eugene Marquis

Not yet recruiting

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer (CRANIUM)

HER2-positive Breast Cancer
Fudan University

Not yet recruiting

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

Triple-negative Breast Cancer
Providence Health & Services
Inhibrx, Inc.

Not yet recruiting

Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients

Triple Negative Breast Cancer

United States
Fudan University

Recruiting

Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China

Breast Neoplasm Female | Financial Toxicity | Financial Navigation

China
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011

Advanced Breast Cancer

China
Fudan University

Not yet recruiting

Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer

Triple-negative Breast Cancer
Filipa Lynce, MD
Merck Sharp & Dohme LLC; Zentalis Pharmaceuticals

Not yet recruiting

A Phase I/II Single-arm Trial of Azenosertib (ZN-c3) Combined With Carboplatin and Pembrolizumab in Patients With Metastatic Triple-negative Breast Cancer (ZAP-IT)

Breast Cancer | Triple Negative Breast Cancer | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor Negative Malignant Tumor Breast Triple

United States
Portsmouth Hospitals NHS Trust
University of East Anglia

Recruiting

Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent (PRC)

Breast Cancer | Complication of Surgical Procedure

United Kingdom
Izmir Bakircay University

Recruiting

Symptoms Associated With Chemotherapy-Induced Peripheral Neuropathy

Breast Cancer | Breast Cancer Female | Chemotherapy-induced Peripheral Neuropathy

Turkey
Fondazione Policlinico Universitario Agostino Gemelli...

Not yet recruiting

New Digital Person-based Care Model in Patients With HER2-negative Advanced Breast Cancer (InPERSON)

Breast Cancer | Patient Satisfaction | Narrative Medicine | HER2-negative Breast Cancer
Roswell Park Cancer Institute

Not yet recruiting

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Breast Carcinoma | Breast Ductal Carcinoma in Situ
Institut Curie

Not yet recruiting

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT) (FAP-IT)

Triple Negative Breast Cancer
International Research Training Group 2804
German Research Foundation; Uppsala University; University Hospital Tuebingen

Not yet recruiting

Breast Cancer & Antiestrogenic Therapy & Brain

Menopause | Breast Cancer Female | Healthy Female | Anti-estrogenic Therapy

Germany
Fondazione Policlinico Universitario Agostino Gemelli...
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Federico II University; Azienda... and other collaborators

Not yet recruiting

Transgender and Gender Diverse Individuals Screening for Breast Cancer (GENESIS)

Breast Cancer
University of Chicago

Not yet recruiting

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Breast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

United States
Istanbul University - Cerrahpasa (IUC)

Recruiting

The Effect of Web-Based Breast Self-Examination Education

Breast Cancer | Education

Turkey
Centro di Riferimento Oncologico - Aviano

Not yet recruiting

Permanence of Indocyanine Green in Axillary Lymph Nodes 3 Weeks After Subdermal Injection in Patients With Breast Cancer and Metastatic Lymph Nodes (FLUO)

Breast Cancer

Italy
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Evaluation of the Effect of Photobiomodulation on Sexual Quality of Life in Women With Breast Cancer (EVABIOSEIN)

Breast Cancer

France
UNC Lineberger Comprehensive Cancer Center
Bellicum Pharmaceuticals

Not yet recruiting

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

Breast Cancer | Triple Negative Breast Cancer | Relapse | Resistant Cancer

United States
Sichuan Baili Pharmaceutical Co., Ltd.
Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

Not yet recruiting

A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast Cancer

HR+HER2- Breast Cancer

China
Aarhus University Hospital
Danish Cancer Society

Recruiting

The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity (FEMA)

Metastatic Breast Cancer | Adiposity | Estrogen-receptor-positive Breast Cancer

Denmark
Fudan University

Recruiting

Abemaciclib, Palbociclib or Dalpiciclib Combined With Endocrine Therapy as First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Breast Cancer

China
University Hospital, Ghent

Not yet recruiting

FAST-FORWARD vs HAI5

Cancer, Breast

Belgium
Fudan University

Recruiting

Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

Breast Cancer

China

Search clinical trials for: Breast cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations